Scientists Reveal Hidden Lymphatic Drainage System Behind the Eye

Scientists have identified a long-missed drainage system at the rear of the eye, revealing a direct route for fluid and metabolic waste to exit into the body’s lymphatic network. The finding, published in Translational Vision Science & Technology, overturns more than 100 years of belief that the eye operated as an isolated organ without lymphatic connections and opens new avenues for treating blinding conditions such as glaucoma and age-related macular degeneration (AMD).

The research team, led by investigators from the University of British Columbia (UBC) and the University of Toronto, named the newly mapped route the posterior ocular lymphatic outflow, or POLO pathway. It appears to transport excess fluid, proteins, and inflammatory debris away from the retina and into surrounding orbital tissues and lymph nodes.

“The retina is one of the most metabolically active parts of the body, constantly generating byproducts that need to be cleared,” said Dr. Neeru Gupta, professor and head of UBC’s department of ophthalmology and visual sciences. “This discovery helps explain how the eye flushes this waste and promises to transform how we think about and treat a range of eye conditions.”

For over a century, medical consensus held that the eye lacked the lymphatic vessels found in nearly every other organ. That view began to shift in 2009, when Dr. Gupta and Dr. Yeni Yücel identified a lymphatic-related drainage route in the front of the eye, which they termed the “uveolymphatic” pathway. However, the back of the eye remained poorly understood despite being the site of some of the most devastating vision-loss diseases.

To map the posterior drainage system, researchers used a combination of magnetic resonance imaging, near-infrared fluorescence imaging, and microscopic analysis in mice. They injected fluorescent tracer molecules into the space behind the retina and tracked their movement. The results showed the tracers passing through tiny lymphatic vessels in the choroid—a vascular layer beneath the retina—and reaching nearby lymph nodes within minutes.

“Because lymphatic vessels in the choroid were thought not to exist, the team used multiple techniques to demonstrate both their presence and function,” said Dr. Yücel, professor and director of ophthalmic pathology at the University of Toronto and a pathologist-scientist at St. Michael’s Hospital. “We were surprised to see such a direct route for fluid to leave the eye and connect with the lymphatic system.”

The discovery carries significant implications for eye health. AMD alone affects approximately 2.5 million Canadians. Conditions like glaucoma and macular degeneration are linked to the accumulation of fluid, cellular waste, and inflammatory material in the back of the eye, but the mechanism by which these substances are normally removed was unclear.

Dr. Gupta noted that the findings provide a new framework for understanding disease mechanisms. “This gives us a whole new framework for understanding these diseases and a potential target for therapeutics,” she said. “The question now is: How can we enhance or exploit this cleanup system to treat or even prevent disease.”

Potential future applications include therapies designed to boost fluid clearance to reduce inflammation and tissue damage, as well as improved methods for delivering medications to deep eye structures. However, researchers caution that the study was conducted in mice, and further research is needed to confirm how the POLO pathway functions in humans and whether its disruption contributes to human eye disease.

The work was supported by the Canadian Institutes of Health Research, Glaucoma Research Society of Canada, Henry Farrugia Ophthalmology Research Fund, Canadian Space Agency, Dorothy Pitts Chair, Stephen M. Drance Chair, Thor and Nicky Eaton Research Fund, and the Canada Foundation for Innovation Leaders Opportunity Fund.